← All Sponsors
SPONSOR

Mao Jianhua

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Systemic Lupus Erythematosus (SLE)ChildrenBlinatumomab
NCT06789107 Phase 1
Recruiting

Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)
China View Trial →